ClinicalTrials.gov
ClinicalTrials.gov Menu

Zalutumumab in Non-Small Cell Lung Cancer (NSCLC) Patients Refractory to Tyrosine Kinase Inhibitors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01449357
Recruitment Status : Withdrawn (Trial never initiated)
First Posted : October 10, 2011
Last Update Posted : October 10, 2011
Sponsor:
Information provided by (Responsible Party):
Genmab

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Study Completion Date : No date given